@article{16ea60aea5ad4954b1c6fd7f07932ccc,
title = "Perspectives on Use of the Cutaneous Direct Immunofluorescence Assay",
author = "Lehman, \{Julia S.\} and Culton, \{Donna A.\} and Bridges, \{Alina G.\}",
note = "Funding Information: Corresponding Author: Azael Freites-Martinez, MD, Dermatology Service, Oncodermatology Clinic, Hospital Ruber Juan Bravo, Calle Juan Bravo, 49 duplicate, 28006 Madrid, Spain (
[email protected]). Published Online: May 4, 2022. doi:10.1001/jamadermatol.2022.1113 Conflict of Interest Disclosures: Dr Freites-Martinez reported personal fees from ISDIN, Cantabria Labs, and Shook, Hardy, Bacon LLP as well as grants from L'Or{\'e}al Spain and nonfinancial support from Pierre Fabre outside the submitted work. Dr Shapiro reported personal fees from Shook, Hardy, Bacon LLP and holds shares in Replicel Life Sciences. Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the Universidad Europea.",
year = "2022",
month = jun,
doi = "10.1001/jamadermatol.2022.1399",
language = "English (US)",
volume = "158",
pages = "704--705",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "6",
}